SINTX Q3 net loss narrows 55% to $1.6 million; revenue rises to $2.2 million
SINT•SINTX Technologies’ third-quarter 2026 net loss narrowed 55% to approximately $1.6 million, while revenue rose to approximately $2.2 million. Gross margin increased to approximately 62% from 45%.
1. Quarterly results
SINTX Technologies reported third-quarter 2026 revenue of approximately $2.2 million and a net loss of approximately $1.6 million, down 55%. Gross margin rose to approximately 62% from 45%, reflecting improved pricing, higher manufacturing volumes and increased production efficiencies.
2. Cash and product sales
Cash totaled approximately $2 million at quarter-end, and subsequent Class B warrant exercises generated approximately $2 million in gross proceeds. Initial commercial sales of the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System are underway after completion of its limited-use release.
